From: The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs
All effects estimated relative to not-fatigued (NF) population, (Standard Errors in Parentheses) | ||||||
---|---|---|---|---|---|---|
 | Employment: Adjusted odds ratio (OR) of working in the prior 4 weeks relative to NF sample | |||||
 | Model with reported education | Model with imputed education | ||||
Incremental Expenditures attributed to CFS | 0.15*** (0.10) | 0.12*** (0.08) | ||||
Incremental Expenditures Attributed to ISF | 0.14*** (0.08) | 0.14*** (0.08) | ||||
 | Earnings over the past 4 weeks ($), adjusted impact measured relative to NF sample | |||||
 | Linear OLS | GLM gamma for (y+1) | TPM | |||
 | Model with reported education | Model with imputed education | Model with reported education | Model with imputed education | Model with reported education | Model with imputed education |
Incremental Expenditures attributed to CFS | -878.24** (337.60) | -1079.47*** (347.64) | -503.11 (392.52) | -658.30** (298.83) | -266.30 (261.26) | -394.96 (255.41) |
Incremental Expenditures Attributed to ISF | -408.37* (284.75) | -405.39 (283.90) | -1019.04 (654.78) | -1029.23 (665.62) | -22.37 (235.84) | -25.94 (235.60) |
AIC | 8397.40 | 8398.11 | 17.32 | 17.31 | 538.28 | 538.28 |
BIC | 8451.49 | 8452.20 | -1509.96 | -1511.78 | -1399.67 | -1399.46 |